Executive Summary
The July 20, 2026, filings reveal a significant uptick in corporate restructuring and consolidation activity across Indian sectors, with a clear emphasis on internal reorganization, subsidiary funding, and strategic bolt-on acquisitions. A dominant theme is the use of schemes of arrangement (demergers and amalgamations) by companies like India Glycols and Dr.
Agarwal's Health Care to unlock value and streamline operations, while others like Tech Mahindra and Rubicon Research are simplifying their corporate structures through internal mergers. Capital deployment is heavily skewed towards infusing growth capital into wholly-owned subsidiaries, as seen with Minda Corporation, Rudra Gas, and Anant Raj, indicating a preference for internal expansion over external M&A. The most material and market-moving event is the completion of the Torrent Pharmaceuticals-J.B. Chemicals amalgamation, a landmark consolidation in the pharma sector. While most filings carry a neutral sentiment, the underlying activity suggests a market in a phase of structural realignment, with companies positioning for future growth through portfolio optimization and strategic investments in high-potential areas like green mobility and data centers.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: M&A
Tracking the trend? Catch up on the prior India Sector Consolidation Regulatory Filings digest from July 19, 2026.
Investment Signals (10)
- Torrent Pharmaceuticals ↓ (BULLISH)▲
Completed landmark amalgamation with J.B. Chemicals, issuing 4.19 Cr shares at a 51:100 ratio. This creates a pharma powerhouse with enhanced scale, market share, and cost synergies. Post-merger, Torrent's equity base expanded by 12.4%, but the long-term EPS accretion potential is significant
- Minda Corporation ↓ (BULLISH)▲
Infused ₹25 Cr into its wholly-owned EV subsidiary, Spark Minda Green Mobility. The subsidiary's turnover grew 32.3% YoY (to ₹53.62 Cr), signaling strong momentum in the EV components space. This capital injection positions Minda to capture a larger share of the growing EV market
- India Glycols ↓ (BULLISH)▲
Received NCLT approval for a demerger into two separate listed entities (Bio Pharma and Spirits & Biofuel). With 100% shareholder and creditor approval, this unlocks hidden value, allowing investors to directly play the pharma and biofuel themes. The appointed date is April 1, 2026, making it a near-term catalyst
- CAMS (BULLISH)▲
Completed the acquisition of Fintuple Technologies for ₹96.67 Lakhs, making it a wholly-owned subsidiary. This small-ticket acquisition likely brings in technology capabilities to bolster CAMS's core registry and fund administration business, enhancing its competitive moat
-
Acquired a 100% stake in a shell company (Tanwar Cargo) for ₹85 Cr to secure 9.9 acres of land in Haryana. While the target has nil turnover, the land acquisition for future expansion is a strategic move. The high materiality (8/10) warrants monitoring for execution on expansion plans [NEUTRAL/BULLISH]
- Anant Raj ↓ (BULLISH)▲
Invested a massive ₹74.86 Cr into its subsidiary Ashok Cloud (nil turnover for 3 years) to develop a data center business. This is a high-conviction, long-term bet by the parent. The sheer size of the investment relative to the subsidiary's negligible net worth (₹4.39 Lakh) signals a major strategic pivot into the high-growth cloud/data center space
- Rudra Gas Enterprise ↓ (BULLISH)▲
Increased stake in its subsidiary to 50.95% with a ₹3.5 Cr investment. The subsidiary's turnover grew from nil to ₹3.22 Cr in FY26, indicating it is gaining traction in executing tenders. This is a positive signal for the group's diversification into green energy
- ASI Industries ↓ (NEUTRAL)▲
Acquired a 0.041% stake in Lloyds Engineering Works for ₹5.27 Cr. Lloyds Engineering has shown stellar growth (39.2% YoY revenue growth in FY26, 11.2% PAT margin). While a tiny stake, it could be a precursor to a larger strategic partnership or a portfolio investment by ASI management
-
Both companies are proceeding with a Scheme of Amalgamation, with an NCLT hearing scheduled for August 19, 2026. This consolidation within the promoter group will simplify the corporate structure and create a single, larger entity for the eye care business [NEUTRAL/BULLISH]
-
Acquired a 100% stake in a newly incorporated Japanese entity for a nominal ₹30,000. This is a low-cost, low-risk entry into the Japanese engineering services market, with significant upside optionality if the subsidiary gains traction [NEUTRAL/BULLISH]
Risk Flags (8)
- SG Mart / Land Acquisition Risk↓ [HIGH RISK]▼
The company is paying ₹85 Cr for a target (Tanwar Cargo) with nil turnover for three years. The sole asset is 9.9 acres of land. If the expansion plans fail to materialize or the land faces title/regulatory issues, the entire investment could be impaired. The high materiality (8/10) amplifies this risk
- Anant Raj / Execution Risk↓ [HIGH RISK]▼
The ₹74.86 Cr investment in Ashok Cloud is a high-stakes bet. The subsidiary has nil turnover and a net worth of just ₹4.39 Lakh. The data center business is capital-intensive and competitive. Any delays or cost overruns could strain Anant Raj's balance sheet
- Rudra Gas Enterprise / Dilution Risk↓ [MEDIUM RISK]▼
While the company invested more capital, its shareholding in the subsidiary *decreased* from 51% to 50.95%. This suggests other investors are also participating, potentially diluting Rudra Gas's control and future earnings from the subsidiary
- Tech Mahindra / Merger Complexity↓ [LOW RISK]▼
The scheme to merge three wholly-owned subsidiaries is routine, but the NCLT process is ongoing. Any shareholder representations filed within the 30-day notice period could delay the process, creating near-term uncertainty
- Marksans Pharma / Lack of Deal Transparency↓ [MEDIUM RISK]▼
The company completed the acquisition of ABCnow GmbH but disclosed no financial details (valuation, revenue, or rationale). This lack of transparency makes it difficult for investors to assess the deal's value and potential EPS impact
- Rubicon Research / Fast-Track Merger↓ [LOW RISK]▼
The merger of Kia Health Tech is a fast-track process, which is generally smoother. However, the appointed date is April 1, 2026, and any procedural delays could create accounting complexities for the current fiscal year
- ASI Industries / Minor Stake Risk↓ [LOW RISK]▼
The 0.041% stake in Lloyds Engineering is purely a financial investment. It provides no control or board representation. The value of this investment is entirely subject to market price fluctuations of Lloyds Engineering's stock
- India Glycols / Demerger Timeline Risk↓ [MEDIUM RISK]▼
While NCLT approval has been received, the certified order is awaited. Any delay in receiving the order or subsequent appeals could push back the effective date and the eventual listing of the two new entities
Opportunities (7)
- Torrent Pharmaceuticals / Post-Merger Synergy Play↓ (OPPORTUNITY)◆
The amalgamation with J.B. Chemicals is complete. The next 12-18 months will be critical for realizing cost and revenue synergies. Investors should track margin expansion and market share gains in the domestic formulations market. The stock could re-rate as synergies become visible
- Minda Corporation / EV Growth Lever↓ (OPPORTUNITY)◆
The ₹25 Cr infusion into Spark Minda Green Mobility, which has 32.3% YoY revenue growth, positions Minda as a direct play on the Indian EV component ecosystem. As EV adoption accelerates, this subsidiary could become a significant value driver for Minda Corporation
- India Glycols / Value Unlock via Demerger↓ (OPPORTUNITY)◆
The demerger will create two pure-play entities: Ennature Bio Pharma and IGL Spirits. This could lead to a significant sum-of-the-parts valuation uplift. Investors can gain targeted exposure to the high-growth bio-pharma or spirits/biofuel sectors
- Anant Raj / Data Center Bet↓ (OPPORTUNITY)◆
The massive ₹74.86 Cr investment into Ashok Cloud is a bold bet on India's data center boom. If executed well, this could transform Anant Raj from a real estate player into a significant player in the digital infrastructure space, commanding a higher valuation multiple
- CAMS / Fintech Capability Enhancement (OPPORTUNITY)◆
The acquisition of Fintuple Technologies, though small, likely adds niche tech capabilities. CAMS has a dominant market position in the RTA space. Any technology upgrade that improves efficiency or adds new services could further widen its moat and drive margin expansion
- SG Mart / Land Bank Appreciation↓ (OPPORTUNITY)◆
The ₹85 Cr acquisition of 9.9 acres in Haryana could prove prescient if the land is used for a high-return project (e.g., warehousing, logistics park) or if the land value appreciates significantly. The key is to monitor the company's announced expansion plans
- Dr. Agarwal's Health Care / Eye Care Consolidation↓ (OPPORTUNITY)◆
The amalgamation of Dr. Agarwal's Eye Hospital into Dr. Agarwal's Health Care will create a larger, more investible entity in the high-growth organized eye care sector. The NCLT hearing on August 19, 2026, is a key catalyst
Sector Themes (5)
- Internal Restructuring Over External M&A◆
A clear majority of filings (Tech Mahindra, Rubicon, Dr. Agarwal's, India Glycols) involve schemes of arrangement (mergers/demergers) rather than third-party acquisitions. This suggests companies are prioritizing portfolio optimization and corporate simplification to unlock value for shareholders.
- Aggressive Capital Infusion into Subsidiaries◆
A significant capital deployment trend is the infusion of large sums into wholly-owned or majority-owned subsidiaries. Minda Corp (₹25 Cr), Rudra Gas (₹3.5 Cr), and Anant Raj (₹74.86 Cr) are all channeling capital into subsidiaries for specific growth initiatives (EV, green energy, data centers), indicating a preference for internal growth engines.
- Pharma Sector Consolidation Continues◆
The Torrent-J.B. Chemicals merger is a landmark event, and the Marksans Pharma acquisition of a German company shows that Indian pharma companies are actively consolidating both domestically and internationally to build scale and expand geographic reach.
- Strategic Land/Asset Acquisition for Future Expansion◆
SG Mart's ₹85 Cr land acquisition and Anant Raj's data center investment highlight a theme of companies securing strategic assets (land, infrastructure) today to capitalize on future growth opportunities in logistics, warehousing, and digital infrastructure.
- Low-Cost, High-Option-Value International Forays◆
Technocraft's acquisition of a Japanese entity for a nominal sum is a pattern of making small, low-risk bets to establish a beachhead in new international markets. This allows companies to test the waters without significant capital outlay.
Watch List (8)
-
The hearing for the Scheme of Amalgamation is scheduled for August 19, 2026. The outcome will determine the timeline for the consolidation of the eye care business. Watch for any objections or delays.
-
The certified order for the demerger is awaited. The effective date and timeline for listing of the two new entities (Ennature Bio Pharma and IGL Spirits) will be key catalysts. Monitor for any appeals against the order.
-
The company has until December 31, 2026, to complete the acquisition of Tanwar Cargo. Watch for further announcements regarding the intended use of the 9.9-acre land parcel and any new business plans.
-
Monitor for any announcements regarding the development of the data center, including tie-ups with cloud service providers (AWS, Azure, etc.) or the commencement of commercial operations. This is a high-risk, high-reward project.
-
Track quarterly results for the next 2-3 quarters to assess the financial impact of the J.B. Chemicals merger. Key metrics to watch are revenue growth, margin expansion, and debt reduction.
-
The lack of financial details on the German acquisition is a concern. Watch for any future filings that provide clarity on the target's revenue, profitability, and strategic rationale for the acquisition.
-
The subsidiary's strong 32.3% YoY growth is impressive. Watch for further order wins from EV OEMs and any announcements of capacity expansion, which would confirm the growth trajectory.
-
Shareholders have 30 days from receipt of the NCLT notice to file representations. Monitor for any significant objections that could delay the merger of the three subsidiaries.
Filing Analyses
(14)
20-07-2026
SG Mart Limited's Board approved the acquisition of 100% of Tanwar Cargo Solutions Private Limited for ₹85,00,00,000 (₹85 Crore) to secure 9.956 acres of freehold land in Haryana for future expansion. The Board also appointed Shri Sanjay Gupta as Chairman & Managing Director and Shri Rohan Gupta as Whole-time Director, along with other director appointments. The company approved unaudited financial results for the quarter ended June 30, 2026, though no financial figures were disclosed in the filing.
- · Tanwar Cargo Solutions Private Limited has had nil turnover for the last three financial years (FY 2023-24, FY 2024-25, FY 2025-26).
- · The acquisition is expected to be completed by December 31, 2026.
- · Shri Sanjay Gupta is the father of Shri Rohan Gupta, and both are related as per the disclosure.
- · Shri Chakram Kumar Singh has nearly 30 years of experience and currently serves as Whole-time Director & COO of APL Apollo Tubes Limited.
- · Ms. Shruti Shrivastava founded Sagus Legal in 2020, growing it from 3 to over 40 members in six years.
20-07-2026
Technocraft Industries (India) Limited, through its subsidiary Technosoft Engineering Projects Ltd, has acquired 100% equity stake in a newly incorporated Japanese entity, Technosoft Integrated Solutions K.K., for JPY 50,000 (approx. ₹30,000). The target company, incorporated in November 2025, has nil turnover and has not yet commenced operations; the acquisition is aimed at expanding the group's engineering and technology services business in Japan.
- · Target company was incorporated on November 7, 2025 in Tokyo, Japan.
- · Target company has not yet started business operations and has nil turnover.
- · Acquisition is not a related party transaction.
- · Completion of acquisition is expected within 90 days from the filing date.
- · No governmental or regulatory approvals are required for the acquisition.
20-07-2026
Tech Mahindra Limited is proceeding with a scheme of merger by absorption of its three wholly-owned subsidiaries—Zen3 Infosolutions Private Limited, Tech Mahindra Enterprise Services Limited (formerly Tech Mahindra Defence Technologies Limited), and Begig Private Limited—into itself. The National Company Law Tribunal (NCLT), Mumbai Bench, has dispensed with the meeting of members and creditors and directed the company to issue notices to equity shareholders, who have 30 days to file any representations. The merger is a routine internal restructuring with no financial details disclosed, and no negative or flat performance metrics are present in this filing.
- · The NCLT Mumbai Bench orders dated 12th February 2026 and 2nd June 2026 directed the company to issue notices to equity shareholders.
- · Shareholders have 30 days from receipt of notice to file representations with the Tribunal; otherwise, no representation is presumed.
- · The meeting of members and creditors of the transferee company has been dispensed with by the Tribunal.
- · The scheme documents, including the NCLT orders and the scheme itself, are available on the company's website at specified URLs.
20-07-2026
Marksans Pharma Ltd. has completed the acquisition of 100% share capital of ABCnow GmbH, a Germany-based company, as intimated under Regulation 30 of SEBI (LODR) Regulations, 2015. The acquisition was previously announced on July 8, 2026, and has now been finalized. No financial details or terms of the deal have been disclosed in this filing.
- · The acquisition was previously intimated on July 8, 2026.
- · ABCnow GmbH is based in Germany.
- · The company has acquired 100% share capital of ABCnow GmbH.
20-07-2026
Dr. Agarwal's Health Care Limited has published newspaper advertisements in Business Standard (English) and Makkal Kural (Tamil) on July 20, 2026, giving notice of the hearing of its petition for a Scheme of Amalgamation between Dr. Agarwal's Eye Hospital Limited and Dr. Agarwal's Health Care Limited. The hearing is scheduled before the Hon'ble National Company Law Tribunal, Chennai Bench, on August 19, 2026, pursuant to its order dated July 15, 2026. This is a procedural disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015, and does not contain any financial figures or performance metrics.
- · The NCLT Chennai Bench order was dated July 15, 2026.
- · The hearing is scheduled for August 19, 2026.
- · Advertisements were published in Business Standard (English) and Makkal Kural (Tamil) on July 20, 2026.
- · The scheme is under Sections 230 to 232 of the Companies Act, 2013.
20-07-2026
Rubicon Research Limited's Board approved the Scheme of Merger for its wholly owned subsidiary Kia Health Tech Private Limited, with an appointed date of April 1, 2026. No shares or consideration will be issued, so shareholding and voting rights remain unchanged. The Board also set the 27th AGM for August 26, 2026, and fixed August 7, 2026 as the record date for the recommended final dividend of ₹1.50 per equity share for FY 2025-26.
- · The Board meeting commenced at 4:30 PM IST and concluded at 5:00 PM IST on July 20, 2026.
- · The merger is under Section 233 of the Companies Act, 2013 (fast-track merger for wholly owned subsidiaries).
- · Detailed merger disclosures were previously filed on February 3, 2026 and remain available on the company's website, BSE, and NSE.
- · The Scheme remains subject to statutory, regulatory, shareholder, and creditor approvals.
- · The final dividend of ₹1.50 per share is subject to member approval at the AGM and tax deduction at source.
20-07-2026
Dr. Agarwal's Eye Hospital Ltd. has published newspaper advertisements in Business Standard (English) and Makkal Kural (Tamil) on July 20, 2026, giving notice of the hearing of its petition for a Scheme of Amalgamation with Dr. Agarwal's Health Care Limited. The hearing is scheduled for August 19, 2026, pursuant to the order of the Hon'ble National Company Law Tribunal, Chennai Bench dated July 15, 2026. This is a procedural step in the amalgamation process and does not contain any financial figures or performance data.
- · The NCLT Chennai Bench order was dated July 15, 2026.
- · Advertisements were published in Business Standard (English) and Makkal Kural (Tamil).
- · The hearing is scheduled for August 19, 2026.
- · The scheme is under Sections 230 to 232 of the Companies Act, 2013.
20-07-2026
Computer Age Management Services Limited (CAMS) has completed the acquisition of shares held by the founders of Fintuple Technologies Private Limited for a consideration of ₹96.67 Lacs, making Fintuple a wholly-owned subsidiary of CAMS. The acquisition was previously announced on May 4, 2026, and this filing serves as a completion update. No financial performance metrics or period-over-period comparisons are provided in this filing.
- · The acquisition was initially disclosed on May 4, 2026, via an outcome of the board meeting.
- · Fintuple has become a wholly-owned subsidiary of CAMS following the completion of the share acquisition.
- · The filing is made under Regulation 30 of SEBI (LODR) Regulations, 2015.
20-07-2026
Rudra Gas Enterprise Limited has invested an additional ₹3,50,00,000 (Three Crores Fifty Lakhs) in its subsidiary, Rudra Global Green Energy Private Limited, by subscribing to 35,00,000 equity shares at ₹10 each. Post-allotment, the subsidiary's paid-up capital increased from ₹1,00,000 to ₹6,88,00,000, while Rudra Gas's shareholding slightly decreased from 51% to 50.95%. The investment is classified as a related-party transaction but was conducted at arm's length, and the funds will be used to execute existing and future tenders.
- · The subsidiary was incorporated on 03/01/2025 and had nil turnover for the year ended 31/03/2025.
- · The subsidiary's turnover as of 31/03/2026 was ₹3,22,44,157.
- · Rudra Gas's shareholding in the subsidiary decreased from 51% to 50.95% post-allotment.
- · The investment is a related-party transaction but was done at arm's length.
20-07-2026
India Glycols Limited (IGL) has received NCLT approval for a scheme of arrangement to demerge its Bio Pharma undertaking into Ennature Bio Pharma Limited and its Spirits and Biofuel undertaking into IGL Spirits Limited, with an appointed date of April 1, 2026. The scheme was unanimously approved by all equity shareholders (100% in favor) and unsecured creditors (100% in favor by value). The certified order is awaited, and the effective date will be communicated separately.
- · The NCLT order was pronounced on July 17, 2026, and uploaded on the NCLT website on July 20, 2026.
- · The appointed date of the scheme is April 1, 2026.
- · The scheme was unanimously approved by all equity shareholders (4,42,48,625 votes in favor out of 4,42,48,626 cast) and by all unsecured creditors who voted (36 creditors representing ₹64,266.50 Lakh in value).
- · The Regional Director noted that no prosecution or scrutiny/inquiry is pending against any of the petitioner companies under the Companies Act, 2013.
- · The demerged company confirmed that no-objection letters from BSE and NSE under Regulation 37 of SEBI LODR were obtained and placed on record.
20-07-2026
Minda Corporation Limited (MCL) has acquired an additional 2,50,00,000 equity shares of its wholly owned subsidiary Spark Minda Green Mobility Systems Private Limited for INR 25 Crore (Rs. 25,00,00,000) through a rights issue, completed on July 19, 2026. The investment maintains MCL's 100% shareholding and provides growth capital for the subsidiary's business requirements. The subsidiary's turnover has grown steadily from Rs. 3544.12 Lakh in FY 2023-24 to Rs. 4053.33 Lakh in FY 2024-25 and further to Rs. 5362.07 Lakh in FY 2025-26, reflecting a 32.3% YoY increase in the latest fiscal year.
- · The acquisition was completed on July 19, 2026, and the consideration was paid in cash through normal banking channels.
- · The subsidiary, Spark Minda Green Mobility Systems Private Limited, was incorporated on February 22, 2021, under CIN U34100DL2021PTC377353.
- · The transaction does not fall within related party transactions as per the Companies Act, 2013 and SEBI Listing Regulations.
- · No governmental or regulatory approvals were required for the acquisition.
20-07-2026
Torrent Pharmaceuticals Limited has completed the allotment of 4,19,22,416 equity shares to eligible shareholders of J. B. Chemicals & Pharmaceuticals Limited as part of the amalgamation scheme sanctioned by the NCLT. The share exchange ratio was 51 Torrent Pharma shares for every 100 JB Chemicals shares. Post-allotment, Torrent Pharma's issued and paid-up equity share capital increased from ₹1,69,22,27,200 to ₹1,90,18,39,280.
- · The share exchange ratio was 51 Torrent Pharma shares (face value ₹5 each) for every 100 JB Chemicals shares (face value ₹1 each).
- · The record date for determining eligible JB Chemicals shareholders was July 17, 2026.
- · The NCLT Ahmedabad Bench sanctioned the scheme on July 6, 2026.
- · The allotted shares rank pari passu with existing Torrent Pharma shares in all respects.
20-07-2026
ASI Industries Ltd has acquired 6,05,289 equity shares (0.041% stake) of Lloyds Engineering Works Ltd for a total cash consideration of ₹5.27 Crore on the stock exchange, purely for investment purposes. The target entity reported a turnover of ₹1052.22 Crore, PAT of ₹118.27 Crore, and net worth of ₹1595.31 Crore as of FY25-26. The acquisition is not a related-party transaction and does not involve any change in management control. The transaction is small in size relative to the target's scale, indicating a passive minority investment.
- · The acquisition was executed on 17th July 2026 at 3:30 PM, but the company intimated the exchange on 20th July 2026 after business hours, citing delay in receiving detailed particulars.
- · Lloyds Engineering Works reported consistent YoY turnover growth: 21.1% in FY24-25 and 39.2% in FY25-26.
- · The target entity's PAT for FY25-26 was ₹118.27 Crore, indicating a net profit margin of approximately 11.2%.
- · ASI Industries has stated it does not intend to acquire control of the target's management.
20-07-2026
Anant Raj Limited's Finance and Investment Committee approved an additional investment of ₹74,86,45,106 (₹74.86 Crore) in its wholly owned subsidiary Ashok Cloud Private Limited (ACPL) via a rights issue of 37,43,22,553 equity shares at ₹2 face value each. The investment will increase ACPL's paid-up capital from ₹5,00,000 to ₹74,91,45,106, while Anant Raj's 100% shareholding remains unchanged. ACPL, which has reported nil turnover for the past three financial years (FY24, FY25, FY26) and a net worth of only ₹4.39 Lakh as of March 31, 2026, will use the funds to develop its data center and cloud business.
- · ACPL has reported nil turnover for the past three financial years: FY24, FY25, and FY26.
- · ACPL's net worth as of March 31, 2026, was only ₹4.39 Lakh.
- · The rights issue is exempt from related party transaction provisions under Regulation 23(5) of SEBI Listing Regulations.
- · No governmental or regulatory approvals are required for the acquisition.
- · The Finance and Investment Committee meeting lasted from 2:20 PM to 2:50 PM on July 20, 2026.
Get daily alerts with 10 investment signals, 8 risk alerts, 7 opportunities and full AI analysis of all 14 filings
₹500/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: India Sector Consolidation Regulatory Filings
July 18, 2026
India Sector Consolidation Regulatory Filings — July 18, 2026
July 17, 2026
India Sector Consolidation Regulatory Filings — July 17, 2026
July 16, 2026
India Sector Consolidation Regulatory Filings — July 16, 2026
July 15, 2026
India Sector Consolidation Regulatory Filings — July 15, 2026
🇮🇳 More from India
View all →July 21, 2026
India Quarterly Results BSE NSE Announcements — July 21, 2026
India Quarterly Results BSE NSE Announcements
July 21, 2026
India Upcoming Corporate Actions BSE NSE — July 21, 2026
India Upcoming Corporate Actions BSE NSE
July 21, 2026
India Pre-Market Regulatory Roundup — July 21, 2026
India Pre-Market Regulatory Roundup
July 21, 2026
India Merger Acquisition MCA Regulatory Filings — July 21, 2026
India Merger Acquisition MCA Regulatory Filings